This message contains images. If you don't see images, click here to view.
Advertise in this news brief.


Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit December 16, 2014
Advertisement
   NAMCP Medical Directors Institute   AAMCN    AAIHDS    Conferences    JMCM    Contact Us  

Fall Managed Care Forum
Nov. 13-14, 2014
Bellagio Hotel
Las Vegas Nevada


Click here to visit the conference website.

Click Here to view our Complimentary Online CME/CEU Webcasts

Otezla® (apremilast) is approved for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Please click here for more information.

 



2014 Innovation Award Winners
NAMCP, AAMCN and AAIHDS are pleased to announce the winners of the first annual Innovation Awards, which recognize a company or organization that is improving outcomes, costs or quality using an innovative method in the workplace. The award winners are as follows:

NAMCP Medical Directors Institute Innovation Award Winner: Yale-New Haven

AAMCN Innovation Award Winner: MDWise

AAIHDS Innovation Award Winner: Keystone First, an affiliate of AmeriHealth Caritas
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Save the date: 2015 Spring Managed Care Forum

Save the date for the 2015 Spring Forum being held April 23-24, 2015 at Disney's Yacht & Beach Club. More information will be available shortly.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


MANAGED HEALTHCARE NEWS
Click Here to visit the Population Health Management Institute


Ebola and the year of horrors and heroes
By Joan Spitrey
Time magazine recently announced its Person of the Year: the Ebola fighters. The runners-up included notable people such as Vladimir Putin and the Ferguson protestors. All of those considered where notable newsmakers this year, but nothing captivated the news — especially within healthcare — than Ebola and the brave souls fighting this enormous fight. This past year a small, microscopic virus showed the world its strength. It spotlighted our deficits in disease control and prevention.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Forbidden topic in health policy debate: Cost effectiveness
The New York Times
If there was a pill that would extend your life by one day, but it cost a billion dollars, it’s unlikely that many people would argue that health insurance should pay for it. We all understand that while the benefit might be real and quantifiable, it’s not worth the expense. But what if the pill cost a million dollars? And what if it extended your life by 10 years?
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Measure, Monitor Immunoglobulin Treatment Outcomes
BioFeedback for immunoglobulin is a health outcomes reporting program that provides clinical feedback on the use of immunoglobulin in autoimmune-related disorders. Physicians and medical directors can now deploy clinical interventions when they have the greatest impact on healthcare quality and costs.

Request more information or schedule a personal introduction.
 


What's behind high generic drug prices?
By Mike Wokasch
Skyrocketing generic drug prices have gotten the attention of patients, insurance companies, healthcare providers and the media. So much so that it prompted a congressional hearing citing federal records that suggest prices for more than 1,200 generic medications increased an average of 448 percent between July 2013 and July 2014. In other words, the price increases are dramatic and are not just for a few isolated cases, but rather involve a broad range of common generic drugs across therapeutic categories.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ACCOUNTABLE CARE ORGANIZATIONS


AHA: New ACO regulations 'may be moving in the wrong direction'
Hospitals & Health Networks
The Medicare Shared Savings Program has hit a few bumps in its second year, with some accountable care organization participants failing to hit their targets. The feds hope that new rules, proposed earlier this month, will help to build momentum in the accountable care movement, but others — such as the American Hospital Association — are concerned that the changes don’t go far enough.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
What is Solesta?

What does a good day mean for your patients?

LEARN MORE
Advertise here!

To find out how to feature your company in the NAMCP eNewsletter and other advertising opportunities, Contact Geoffrey Forneret at 469-420-2629.
MORE


FDA: NEW TREATMENTS & TECHNOLOGY


FDA approves new version of cervical cancer vaccine
The New York Times
The drug maker Merck received approval for an updated version of its Gardasil vaccine, which protects against the virus that causes most cases of cervical cancer. The Food and Drug Administration approved Gardasil 9, which protects against nine strains of the virus called HPV, or human papillomavirus, up from four strains covered by the original vaccine approved in 2006.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Edwards CEO hopes FDA to accelerate approvals of medical devices
Reuters
U.S. health regulators appear open to speeding up approvals of medical devices that currently often reach European markets three to five years ahead of being cleared in the United States, the chief executive officer of Edwards Lifesciences said.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  InSightec - World Leader in MRgFUS

MRgFUS is being used in clinics across America to treat uterine fibroids and pain palliation for metastatic bone tumors. It’s a completely non-invasive procedure performed on an outpatient basis where patients report an improvement in QoL within days, not weeks. Discover InSightec now.
 


GENOMICS & BIOTECH
Click Here to visit the Genomics, Biotech & Emerging Medical Technology Institute


Loops and folds of our DNA to shed light on disease
New Scientist
A lot of things look clearer in 3-D, and that goes for the genome too. The human genome was sequenced about 10 years ago, but that still left us with much to learn about its structure and function. Some of the gaps have since been filled, but how our full complement of DNA — 1.8 metres long when stretched out –— fits into the nuclei of our cells remained elusive.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Nature, nurture both figure into antisocial behavior
PsychCentral
If you happen to carry a particular variant for one of three common genes, you may be more likely to engage in antisocial behavior, but only if you were exposed to an abusive or adverse environment in childhood, according to a new study. The findings confirm previous studies that show how negative experiences can influence how genetic variants affect the brain, and therefore promote negative behavior, according to a new study.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Advancement revolutionizes hereditary cancer testing

Myriad myRisk™ Hereditary Cancer utilizes both genetic test status AND personal cancer family history to identify elevated risk for 8 important cancers by analyzing multiple, clinically significant genes. Myriad myRisk improves clinical sensitivity by 40-50% compared to current testing paradigms in a cost-effective manner, providing more value to your members.
 


PREVENTION & WELLNESS
Click Here to visit the Center for Preventive Health and Lifestyle Medicine


Automated drug-refill reminders increase adherence rates
By Jennifer S. O'Reilly
Automated drug-refill reminders are everywhere — from a phone call that reminds CVS patients to pick up their medications to texts sent to patients' smartphones from Wal-Mart Pharmacy. A recent study on drug-refill reminders found that adherence rates improved by 2 percent with reminders. This may sound like nothing, but small changes in whether people are taking their meds are a plus, the study's researchers say.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ONCOLOGY
Click Here to visit the Oncology Institute


No link between migraine, breast cancer risk
HealthDay News via WebMD
A large, new study should reassure the millions of American women who have migraine: The debilitating headaches don't raise the risk for breast cancer. "There is no association between migraine and breast cancer risk," said lead researcher Rulla Tamimi, an associate professor of medicine at Harvard Medical School.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Cancer's next big thing — immunotherapy
The Huffington Post
The headlines have been coming all year from some of the biggest names in cancer drug discovery and development — from Merck, Bristol-Myers Squibb and AstraZeneca. And just last month, data from Roche's advanced bladder cancer study lit up the international medical community, pointing toward what could be the first major breakthrough in over 30 years for this dangerous cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


BEHAVIORAL HEALTH
Click Here to visit the Behavioral Health Institute


'60 Minutes' shows insurers deny mental health treatment despite ACA rules
Forbes
Despite more comprehensive health insurance under the Affordable Care Act that includes mandatory coverage for mental health services, the noted TV newsmagazine 60 Minutes shined a light on the issue of patients denied treatment by doctors who never even saw them.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FAST FACTS
"The largest waterborne disease outbreak in United States history occurred in 1993 in Milwaukee when over 400,000 people became ill with diarrhea when the parasite Cryptosporidium was found in the city's drinking water supply."


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    The other reason canned food is raising your blood pressure (TIME)
Healthcare law is not one-size-fits-all, and here's why (The New York Times)
'60 Minutes' cancer doctor's revolutionary idea: Taking big data seriously (Forbes)
5 key changes providers can expect from the new ACO rule proposal (Healthcare Dive)
Why millennials hate their least expensive healthcare option (TIME)

Don't be left behind. Click here to see what else you missed.
 
Managed Care eNews
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Natalie Rodriguez, Senior Content Editor, 469.420.2635   
Contribute news

This edition of the Managed Care eNews was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Dec. 9, 2014
Dec. 2, 2014
Nov. 25, 2014
Nov. 18, 2014



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063